Immunological memory to pathogens is associated with clonal expansion and heightened responsiveness of antigen-specific T cells. Recent work emphasizes that, for efficient protective immunity, qualitative changes in T memory cells are vitally important. Immunological memory is often lifelong and results in a heightened response to the pathogen upon reinfection [3-6]. Since memory at the T cell level is associated with a marked increase in the frequency of antigen-specific lymphocytes, the simplest explanation for the efficiency of secondary (memory) immune responses is that there are more reactive cells available to attack the pathogen than in the primary response. But is an increase in precursor frequency alone sufficient to account for memory? According to a paper published recently in Science by Lauvau et al.
Immunological memory is often lifelong and results in a heightened response to the pathogen upon reinfection [3] [4] [5] [6] . Since memory at the T cell level is associated with a marked increase in the frequency of antigen-specific lymphocytes, the simplest explanation for the efficiency of secondary (memory) immune responses is that there are more reactive cells available to attack the pathogen than in the primary response. But is an increase in precursor frequency alone sufficient to account for memory? According to a paper published recently in Science by Lauvau et al. [7] , the answer seems to be no. In this paper the authors found that priming mice with either live or heat-killed bacteria led to intense proliferation of antigen-specific T cells followed by survival of a proportion of these cells as memory cells. Surprisingly, when the mice were later injected with live bacteria, protective immunity to the pathogen was seen only after priming with live bacteria. Priming with killed bacteria was conspicuously ineffective.
To study the requirements for induced protective immunity, Lauvau et al. [7] examined memory in mice injected intravenously with Listeria monocytogenes, a Gram-positive facultative intracellular bacterium (Table 1) ; immunity to this bacterium is known to be controlled largely by CD8 + T cells. To follow the response of antigen-specific CD8 + cells to the bacterial antigens, the authors utilized the finding that CD8 + cells react to antigenic peptides bound to class I major histocompatibility complex (MHC) molecules and that peptide-specific CD8 + cells can be detected via binding of soluble MHC class I tetramers plus specific peptide [6] .
As expected, priming mice with live bacteria led to marked clonal expansion of specific CD8 + cells in the primary response and even greater expansion in the secondary response. Based on T cell binding of three different peptide-tetramer complexes, the precursor frequency of CD8 + cells for the bacterial antigens rose from undetectable levels before priming to 2-3% of CD8 + cells at the height of the primary response (day 7) and then to about 25% during the secondary response (day 5). Testing the mice 21 days after initial injection of live bacteria showed strong protective immunity. Thus, when the mice received a second intravenous injection of live bacteria, counts of viable bacteria in the spleen measured 3 days later were far lower than were found at this time in the primary response.
These results refer to priming with live bacteria. When mice were primed with heat-killed bacteria, clonal expansion and persistence of specific CD8 + cells was as high as for priming with live bacteria. Thus, when mice were primed with killed bacteria and then challenged with live bacteria 21 days later, 27% of CD8 + cells in the spleen were antigen-specific on day 5 after challenge (compared with 24% for mice primed -and challenged -with live virus). Despite this In light of this finding, the authors were faced with a paradox: when challenged with live bacteria after priming with killed bacteria, immunity in the spleen was undetectable even though the spleen contained very large numbers of specific CD8 + cells. The authors' explanation for this puzzle is that the specific CD8 + cells failed to express effector function. In support of this idea, adoptive transfer studies with T cell receptor transgenic mice specific for one of the bacterial peptides showed that differentiation of CD8 + cells into cytotoxic T lymphocytes and interferon-γ γ-producing cells was conspicuous in hosts primed with live bacteria but almost undetectable in hosts given killed bacteria. With the latter, the failure of the transgenic CD8 + cells to differentiate into effector cells correlated with a small (twofold) reduction in clonal expansion and impaired downregulation of a lymph node homing receptor, CD62L. To explain these findings, the authors suggested that live and killed bacteria are phagocytosed by different antigen-presenting cells, namely by dendritic cells ('professional' antigen-presenting cells) for live bacteria and macrophages for killed bacteria. The assumption here is that both types of antigen-presenting cell elicit clonal expansion of CD8 + cells but only dendritic cells promote differentiation into effector cells. This interesting idea has yet to be proved.
At face value, these data would seem to provide strong support for the authors' conclusion that the lack of protective immunity after priming with killed bacteria reflected a failure of memory CD8 + cells to differentiate into effector cells. However, in the T cell receptor transgenic model, effector function was studied only in the primary and not the secondary response. This is an important omission because the live bacteria used in the secondary response were presumably highly immunogenic; here, one would expect presentation of antigen by professional antigen-presenting cells to not only induce extensive proliferation of memory cells but also drive these cells to differentiate into effector cells. The only direct evidence presented in the paper on this issue, however, is that bacterial counts measured in the spleen on day 3 were not reduced. This is good evidence for a lack of protective immunity, but it does not prove that the memory cells failed to form effector cells. Perhaps effector cells were formed, but more slowly than in mice primed with live bacteria (see Table 1 But suppose the authors tested this idea and found no evidence of protective immunity and no induction of cytotoxic T lymphocytes? Such a finding would be most intriguing and suggest that the memory CD8 + cells generated after priming with killed bacteria were functionally anergic: the memory cells proliferated extensively when challenged with live bacteria, but, because of aberrant priming, were unable to Whatever the explanation, the apparent incompetence of memory CD8 + cells generated in response to killed bacteria has important implications for vaccine design. With some notable exceptions, for example the Salk vaccine for poliomyelitis, vaccination with killed microorganisms often affords poor protection and may rely largely on humoral immunity via antibody production [11] . Since effective (live) vaccines generally elicit powerful primary responses of T cells, the limited cellular immunity induced by killed microorganisms is usually attributed to weak priming of T cells. This assumption is clearly questioned by the finding of Lauvau et al. [7] that a killed vaccine can induce intense T cell proliferation but provide poor protection. Defining precisely why the memory cells in this situation are incompetent could be vital for improving vaccine design.
